Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-Based Study

Integrative Cancer Therapies

Volumn 17, Issue 2, 2018, Pages 531-541

  Kuo, Yi Ting ^a,b   Chang, Tung Ti ^a,c   Muo, Chih Hsin ^c   Wu, Mei Yao ^c   Sun, Mao Feng ^a,c   Yeh, Chia Chou ^b,d   Yen, Hung Rong ^a,c,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b DALIN TZU CHI HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

acupuncture; cancer; complementary and alternative medicine; National Health Insurance Research Database; traditional Chinese medicine

Indexed keywords

ADULT; AGE; ALTERNATIVE MEDICINE; ANXIETY DISORDER; ARTICLE; BILE DUCT CANCER; BREAST CANCER; CANCER PATIENT; CHINESE MEDICINE; CONSULTATION; CONTROLLED STUDY; DEPRESSION; DIZZINESS; ENDOCRINE DISEASE; FASCIITIS; FATIGUE; FEMALE; GASTROINTESTINAL DISEASE; HEADACHE; HERBAL MEDICINE; HUMAN; IMMUNOPATHOLOGY; INSOMNIA; INTRAHEPATIC BILE DUCT; MAJOR CLINICAL STUDY; MALAISE; MALE; METABOLIC DISORDER; MORTALITY RISK; MYALGIA; PRIORITY JOURNAL; SEX DIFFERENCE; TAIWAN; TIME TO TREATMENT; URBAN AREA; ADOLESCENT; MIDDLE AGED; NEOPLASM; PROCEDURES; YOUNG ADULT;

HERBACEOUS AGENT;

ADOLESCENT; ADULT; COMPLEMENTARY THERAPIES; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; NEOPLASMS; TAIWAN; YOUNG ADULT;

EID: 85047012321     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735417716302     Document Type: Article

References (62)

1. DeSantis CE, Lin CC, Mariotto AB. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252-271.
2. Ministry of Health and Welfare. Statistical Results on Causes of Death in Taiwan (Data Source: Department of Statistics). Taipei, Taiwan ROC: Ministry of Health and Welfare; 2014.
3. Hu Z, Liang W, Yang Y. Personalized estimate of chemotherapy-induced nausea and vomiting: development and external validation of a nomogram in cancer patients receiving highly/moderately emetogenic chemotherapy. Medicine (Baltimore). 2016;95:e2476.
4. Chung VC, Wu X, Lu P. Chinese herbal medicine for symptom management in cancer palliative care: systematic review and meta-analysis. Medicine (Baltimore). 2016;95:e2793.
5. Hu C, Zhang H, Wu W. Acupuncture for pain management in cancer: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2016;2016:1720239.
6. Pu CY, Lan VM, Lan CF, Lang HC. The determinants of traditional Chinese medicine and acupuncture utilization for cancer patients with simultaneous conventional treatment. Eur J Cancer Care (Engl). 2008;17:340-349.
7. Qi F, Li A, Inagaki Y. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends. 2010;4:297-307.
8. Liu SH, Cheng YC. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol. 2012;140:614-623.
9. Chien TJ, Liu CY, Ko PH, Hsu CH. A Chinese decoction, Kuan-Sin-Yin, improves autonomic function and cancer-related symptoms of metastatic colon cancer. Integr Cancer Ther. 2016;15:113-123.
10. Garcia MK, McQuade J, Haddad R. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol. 2013;31:952-960.
11. Bae K, Yoo HS, Lamoury G, Boyle F, Rosenthal DS, Oh B. Acupuncture for aromatase inhibitor-induced arthralgia: a systematic review. Integr Cancer Ther. 2015;14:496-502.
12. Yin SY, Wei WC, Jian FY, Yang NS. Therapeutic applications of herbal medicines for cancer patients. Evid Based Complement Alternat Med. 2013;2013:302426.
13. National Health Insurance Administration. National Health Insurance Annual Report 2015-2016. Taipei, Taiwan ROC: National Health Insurance Administration, Ministry of Health and Welfare; 2015.
14. Lee YW, Chen TL, Shih YR. Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: a population-based study. Cancer. 2014;120:1338-1344.
15. Fleischer T, Chang TT, Chiang JH, Sun MF, Yen HR. Improved survival with integration of Chinese herbal medicine therapy in patients with acute myeloid leukemia: a nationwide population-based cohort study. Integr Cancer Ther. 2017;16:156-164. doi:10.1177/1534735416664171.
16. Fleischer T, Chang TT, Chiang JH, Hsieh CY, Sun MF, Yen HR. Integration of Chinese herbal medicine therapy improves survival of patients with chronic lymphocytic leukemia: a nationwide population-based cohort study. Medicine (Baltimore). 2016;95:e3788.
17. Fleischer T, Chang TT, Chiang JH, Chang CM, Hsieh CY, Yen HR. Adjunctive Chinese herbal medicine therapy improves survival of patients with chronic myeloid leukemia: a nationwide population-based cohort study. Cancer Med. 2016;5:640-648.
18. Hung KF, Hsu CP, Chiang JH. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: a nationwide retrospective matched-cohort study. J Ethnopharmacol. 2017;199:168-174.
19. Tsai TY, Livneh H, Hung TH, Lin IH, Lu MC, Yeh CC. Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study. BMJ Open. 2017;7:e014571.
20. Liu JM, Lin PH, Hsu RJ. Complementary traditional Chinese medicine therapy improves survival in patients with metastatic prostate cancer. Medicine (Baltimore). 2016;95:e4475.
21. Yen HR, Lai WY, Muo CH, Sun MF. Characteristics of traditional Chinese medicine use in pediatric cancer patients: a nationwide, retrospective, Taiwanese-registry, population-based study. Integr Cancer Ther. 2017;16:147-155. doi:10.1177/1534735416659357.
22. Hsing AW, Ioannidis JP. Nationwide population science: lessons from the Taiwan National Health Insurance Research Database. JAMA Intern Med. 2015;175:1527-1529.
23. Huang TP, Liu PH, Lien AS, Yang SL, Chang HH, Yen HR. A nationwide population-based study of traditional Chinese medicine usage in children in Taiwan. Complement Ther Med. 2014;22:500-510.
24. Lien AS, Jiang YD, Mou CH, Sun MF, Gau BS, Yen HR. Integrative traditional Chinese medicine therapy reduces the risk of diabetic ketoacidosis in patients with type 1 diabetes mellitus. J Ethnopharmacol. 2016;191:324-330.
25. Huang MC, Pai FT, Lin CC. Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: a nationwide population-based study. J Ethnopharmacol. 2015;176:9-16.
26. Liu HY, Chuang YL. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;4:1-22.
27. Yen HR, Sun MF, Lin CL, Sung FC, Wang CC, Liang KL. Adjunctive traditional Chinese medicine therapy for patients with chronic rhinosinusitis: a population-based study. Int Forum Allergy Rhinol. 2015;5:240-246.
28. John GM, Hershman DL, Falci L, Shi Z, Tsai WY, Greenlee H. Complementary and alternative medicine use among US cancer survivors. J Cancer Surviv. 2016;10:850-864.
29. Egan B, Gage H, Hood J. Availability of complementary and alternative medicine for people with cancer in the British National Health Service: results of a national survey. Complement Ther Clin Pract. 2012;18:75-80.
30. Kim SH, Shin DW, Nam YS. Expected and perceived efficacy of complementary and alternative medicine: a comparison views of patients with cancer and oncologists. Complement Ther Med. 2016;28:29-36.
31. Rossi E, Vita A, Baccetti S, Di Stefano M, Voller F, Zanobini A. Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe. Support Care Cancer. 2015;23:1795-1806.
32. Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11:187-203.
33. Yeh YH, Chou YJ, Huang N, Pu C, Chou P. The trends of utilization in traditional Chinese medicine in Taiwan from 2000 to 2010: a population-based study. Medicine (Baltimore). 2016;95:e4115.
34. Huang CY, Lai WY, Sun MF. Prescription patterns of traditional Chinese medicine for peptic ulcer disease in Taiwan: a nationwide population-based study. J Ethnopharmacol. 2015;176:311-320.
35. Liao HH, Yeh CC, Lin CC. Prescription patterns of Chinese herbal products for patients with fractures in Taiwan: a nationwide population-based study. J Ethnopharmacol. 2015;173:11-19.
36. Shih CC, Liao CC, Su YC, Tsai CC, Lin JG. Gender differences in traditional Chinese medicine use among adults in Taiwan. PLoS One. 2012;7:e32540.
37. Shih CC, Huang LH, Lane HL. Use of folk therapy in Taiwan: a nationwide cross-sectional survey of prevalence and associated factors. Evid Based Complement Alternat Med. 2015;2015:649265.
38. Shih CC, Liao CC, Su YC, Yeh TF, Lin JG. The association between socioeconomic status and traditional Chinese medicine use among children in Taiwan. BMC Health Serv Res. 2012;12:27.
39. Chang KH, Brodie R, Choong MA, Sweeney KJ, Kerin MJ. Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer. 2011;11:196.
40. Bauml JM, Chokshi S, Schapira MM. Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey. Cancer. 2015;121:2431-2438.
41. Naing A, Stephen SK, Frenkel M. Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience. Cancer. 2011;117:5142-5150.
42. Hack CC, Fasching PA, Fehm T. Interest in integrative medicine among postmenopausal hormone receptor-positive breast cancer patients in the EvAluate-TM Study. Integr Cancer Ther. 2017;16:165-175. doi:10.1177/1534735416668575.
43. Shih CC, Lin JG, Liao CC, Su YC. The utilization of traditional Chinese medicine and associated factors in Taiwan in 2002. Chin Med J (Engl). 2009;122:1544-1548.
44. Huang TP, Liu PH, Lien AS, Yang SL, Chang HH, Yen HR. Characteristics of traditional Chinese medicine use in children with asthma: a nationwide population-based study. Allergy. 2013;68:1610-1613.
45. Weng SW, Chen BC, Wang YC. Traditional Chinese medicine use among patients with psoriasis in Taiwan: a nationwide population-based study. Evid Based Complement Alternat Med. 2016;2016:3164105.
46. Yang G, Lee R, Zhang H, Gu W, Yang P, Ling C. National survey of China’s oncologists’ knowledge, attitudes, and clinical practice patterns on complementary and alternative medicine. Oncotarget. 2017;8:13440-13449. doi:10.18632/oncotarget.14560.
47. Chi C, Lee JL, Lai JS, Chen CY, Chang SK, Chen SC. The practice of Chinese medicine in Taiwan. Soc Sci Med. 1996;43:1329-1348.
48. Lin YH, Shiu JH, Chen FP, Chiu JH. Building an integrative outpatient care program for breast cancer patients in Taiwan. Integr Cancer Ther. 2016;15:343-348.
49. Hsu PY, Yang SH, Tsang NM. Efficacy of traditional Chinese medicine in xerostomia and quality of life during radiotherapy for head and neck cancer: a prospective pilot study. Evid Based Complement Alternat Med. 2016;2016:8359251.
50. Block KI, Block PB, Gyllenhaal C. Integrative therapies in cancer: modulating a broad spectrum of targets for cancer management. Integr Cancer Ther. 2015;14:113-118.
51. Fleischer T, Chang TT, Yen HR. Post-hematopoietic stem cell transplantation in patients with hematologic disorders: Chinese herbal medicine for an unmet need. J Integr Med. 2016;14:322-335.
52. Wortmann JK, Bremer A, Eich HT. Use of complementary and alternative medicine by patients with cancer: a cross-sectional study at different points of cancer care. Med Oncol. 2016;33:78.
53. Davis EL, Oh B, Butow PN, Mullan BA, Clarke S. Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. Oncologist. 2012;17:1475-1481.
54. Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin Med (Lond). 2013;13:126-131.
55. Molassiotis A, Fernadez-Ortega P, Pud D. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16:655-663.
56. Uzuner H, Bauer R, Fan TP. Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities. J Ethnopharmacol. 2012;140:458-468.
57. Chen FP, Kung YY, Chen TJ, Hwang SJ. Demographics and patterns of acupuncture use in the Chinese population: the Taiwan experience. J Altern Complement Med. 2006;12:379-387.
58. Edman JS, Roberts RS, Dusek JA, Dolor R, Wolever RQ, Abrams DI. Characteristics of cancer patients presenting to an integrative medicine practice–based research network. Integr Cancer Ther. 2014;13:405-410.
59. Choi TY, Lee MS, Kim TH, Zaslawski C, Ernst E. Acupuncture for the treatment of cancer pain: a systematic review of randomised clinical trials. Support Care Cancer. 2012;20:1147-1158.
60. Wang SF, Wang Q, Jiao LJ. Astragalus-containing traditional Chinese medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis. Curr Oncol. 2016;23:e188-e195.
61. Tao W, Luo X, Cui B. Practice of traditional Chinese medicine for psycho-behavioral intervention improves quality of life in cancer patients: a systematic review and meta-analysis. Oncotarget. 2015;6:39725-39739.
62. Liao YH, Lin CC, Lai HC, Chiang JH, Lin JG, Li TC. Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients. Liver Int. 2015;35:2595-2602.